Loxapine succinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for loxapine succinate and what is the scope of patent protection?
Loxapine succinate
is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Co Inc, Rising, Watson Labs, and Teva Branded Pharm, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for loxapine succinate. Six suppliers are listed for this compound.
Summary for loxapine succinate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 5 |
NDAs: | 8 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 2 |
Patent Applications: | 1,990 |
Drug Prices: | Drug price trends for loxapine succinate |
What excipients (inactive ingredients) are in loxapine succinate? | loxapine succinate excipients list |
DailyMed Link: | loxapine succinate at DailyMed |
Recent Clinical Trials for loxapine succinate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Witten/Herdecke | Phase 2 |
Mylan Pharmaceuticals | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for loxapine succinate
US Patents and Regulatory Information for loxapine succinate
Expired US Patents for loxapine succinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |